The ACTN3 R577X polymorphism across three groups of elite male European athletes

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Eynon, Nir ^a   Ruiz, Jonatan R ^b,g   Femia, Pedro ^b   Pushkarev, Vladimir P ^c   Cieszczyk, Pawel ^d   Maciejewska Karlowska, Agnieszka ^d   Sawczuk, Marek ^d   Dyatlov, Dmitry A ^c   Lekontsev, Evgeny V ^c   Kulikov, Leonid M ^c   Birk, Ruth ^e   Bishop, David J ^a   Lucia, Alejandro ^f  

^a VICTORIA UNIVERSITY   (Australia)

^b UNIVERSITY OF GRANADA   (Spain)

^c URAL FEDERAL UNIVERSITY   (Russian Federation)

^d UNIVERSITY OF SZCZECIN   (Poland)

^e ARIEL UNIVERSITY   (Israel)

^f UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^g KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

ACTN3 GENE; ADULT; ARTICLE; ATHLETE; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; ETHNIC GROUP; EUROPEAN; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; POLISH; RUSSIAN; SEDENTARY LIFESTYLE; SPANISH;

ACTININ; ADULT; ATHLETES; ATHLETIC PERFORMANCE; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 84865094427     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043132     Document Type: Article

References (32)

1. MacArthur DG, North KN, (2007) ACTN3: A genetic influence on muscle function and athletic performance. Exerc Sport Sci Rev 35: 30-34.
2. MacArthur DG, North KN, (2004) A gene for speed? The evolution and function of alpha-actinin-3. BioEssays 26: 786-795.
3. North KN, Yang N, Wattanasirichaigoon D, Mills M, Easteal S, et al. (1999) A common nonsense mutation results in alpha-actinin-3 deficiency in the general population. Nat Genet 21: 353-354.
4. Yang N, MacArthur DG, Gulbin JP, Hahn AG, Beggs AH, et al. (2003) ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet 73: 627-631.
5. MacArthur DG, Seto JT, Chan S, Quinlan KG, Raftery JM, et al. (2008) An Actn3 knockout mouse provides mechanistic insights into the association between alpha-actinin-3 deficiency and human athletic performance. Hum Mol Genet 17: 1076-1086.
6. MacArthur DG, Seto JT, Raftery JM, Quinlan KG, Huttley GA, et al. (2007) Loss of ACTN3 gene function alters mouse muscle metabolism and shows evidence of positive selection in humans. Nat Genet 39: 1261-1265.
7. Eynon N, Duarte JA, Oliveira J, Sagiv M, Yamin C, et al. (2009) ACTN3 R577X polymorphism and Israeli top-level athletes. Int J Sports Med 30: 695-698.
8. Papadimitriou ID, Papadopoulos C, Kouvatsi A, Triantaphyllidis C, (2008) The ACTN3 gene in elite Greek track and field athletes. Int J Sports Med 29: 352-355.
9. Gineviciene V, Pranculis A, Jakaitiene A, Milasius K, Kucinskas V, (2011) Genetic Variation of the Human ACE and ACTN3 Genes and their Association with Functional Muscle Properties in Lithuanian Elite Athletes. Medicina 47: 284-290.
10. Ahmetov II, Druzhevskaya AM, Lyubaeva EV, Popov DV, Vinogradova OL, et al. (2011) The dependence of preferred competitive racing distance on muscle fibre type composition and ACTN3 genotype in speed skaters. Exp physiol 96: 1302-1310.
11. Roth SM, Walsh S, Liu D, Metter EJ, Ferrucci L, et al. (2008) The ACTN3 R577X nonsense allele is under-represented in elite-level strength athletes. Eur J Hum Genet 16: 391-394.
12. Niemi AK, Majamaa K, (2005) Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sprint athletes. Eur J Hum Genet 13: 965-969.
13. Lucia A, Olivan J, Gomez-Gallego F, Santiago C, Montil M, et al. (2007) Citius and longius (faster and longer) with no alpha-actinin-3 in skeletal muscles? Br J Sports Med 41: 616-617.
14. Druzhevskaya AM, Ahmetov II, Astratenkova IV, Rogozkin VA, (2008) Association of the ACTN3 R577X polymorphism with power athlete status in Russians. Eur J Appl Physiol 103: 631-634.
15. Vincent B, Windelinckx A, Van Proeyen K, Masschelein E, Nielens H, et al. (2011) Alpha-actinin-3 deficiency does not significantly alter oxidative enzyme activity in fast human muscle fibres. Acta physiol. doi: 10.1111/j.1748-1716.2011.02366.x.
16. Ruiz JR, Fernandez Del Valle M, Verde Z, Diez-Vega I, Santiago C, et al. (2010) ACTN3 R577X polymorphism does not influence explosive leg muscle power in elite volleyball players. Scan J Med Sci Sports 21: e34-41.
17. Ahmetov II, Druzhevskaya AM, Astratenkova IV, Popov DV, Vinogradova OL, et al. (2010) The ACTN3 R577X polymorphism in Russian endurance athletes. Br J Sports Med 44: 649-652.
18. Doring FE, Onur S, Geisen U, Boulay MR, Perusse L, et al. (2010) ACTN3 R577X and other polymorphisms are not associated with elite endurance athlete status in the Genathlete study. J Sports Sci 28: 1355-1359.
19. Muniesa CA, Gonzalez-Freire M, Santiago C, Lao JI, Buxens A, et al. (2010) World-class performance in lightweight rowing: is it genetically influenced? A comparison with cyclists, runners and non-athletes. Br J Sports Med 44: 898-901.
20. Saunders CJ, September AV, Xenophontos SL, Cariolou MA, Anastassiades LC, et al. (2007) No association of the ACTN3 gene R577X polymorphism with endurance performance in Ironman Triathlons. Ann Hum Genet 71: 777-781.
21. Yang N, MacArthur DG, Wolde B, Onywera VO, Boit MK, et al. (2007) The ACTN3 R577X polymorphism in East and West African athletes. Med Sci Sports Exerc 39: 1985-1988.
22. Bouchard C, (2011) Overcoming barriers to progress in exercise genomics. Exer Sport Sci Rev 39: 212-217.
23. Eynon N, Ruiz JR, Oliveira J, Duarte JA, Birk R, et al. (2011) Genes and elite athletes: a roadmap for future research. J Physiol 589: 3063-3070.
24. Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, et al. (2007) Replicating genotype-phenotype associations. Nature 447: 655-660.
25. Attia J, Ioannidis JP, Thakkinstian A, McEvoy M, Scott RJ, et al. (2009) How to use an article about genetic association: B: Are the results of the study valid? JAMA 301: 191-197.
26. Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, et al. (2009) Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Hum Genet 125: 131-151.
27. Gomez-Gallego F, Santiago C, Gonzalez-Freire M, Muniesa CA, Fernandez Del Valle M, et al. (2009) Endurance performance: genes or gene combinations? Int J Sports Med 30: 66-72.
28. Tejedor D, Castillo S, Mozas P, Jimenez E, Lopez M, et al. (2005) Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia. Clin Chem 51: 1137-1144.
29. Mills M, Yang N, Weinberger R, Vander Woude DL, Beggs AH, et al. (2001) Differential expression of the actin-binding proteins, alpha-actinin-2 and-3, in different species: implications for the evolution of functional redundancy. Hum Mol Genet 10: 1335-1346.
30. Vincent B, De Bock K, Ramaekers M, Van den Eede E, Van Leemputte M, et al. (2007) ACTN3 (R577X) genotype is associated with fiber type distribution. Physiol Genomics 32: 58-63.
31. Norman B, Esbjornsson M, Rundqvist H, Osterlund T, von Walden F, et al. (2009) Strength, power, fiber types, and mRNA expression in trained men and women with different ACTN3 R577X genotypes. J Appl Physiol 106: 959-965.
32. Bishop D, Jenkins DG, McEniery M, Carey MF, (2000) Relationship between plasma lactate parameters and muscle characteristics in female cyclists. Med Sci Sports Exerc 32: 1088-1093.